- Home
- UNF vs KNSA Comparison
UNF vs KNSA Comparison
Compare UNF & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UNF | KNSA |
|---|---|---|
| Founded | 1936 | 2015 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 4.9B |
| IPO Year | 1994 | 2018 |
Fundamental Metrics
Financial Performance| Metric | UNF | KNSA |
|---|---|---|
| Price | $292.00 | $76.28 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | ★ $238.33 | $60.86 |
| AVG Volume (30 Days) | 140.7K | ★ 771.4K |
| Earning Date | 04-01-2026 | 04-28-2026 |
| Dividend Yield | ★ 0.57% | N/A |
| EPS Growth | 2.70 | ★ 225.00 |
| EPS | ★ 4.11 | 0.27 |
| Revenue | ★ $1,696,489,000.00 | $677,564,000.00 |
| Revenue This Year | $3.69 | $37.48 |
| Revenue Next Year | $3.53 | $17.87 |
| P/E Ratio | ★ $70.91 | $271.89 |
| Revenue Growth | 6.63 | ★ 60.09 |
| 52 Week Low | $147.66 | $31.78 |
| 52 Week High | $306.67 | $82.94 |
Technical Indicators
Market Signals| Indicator | UNF | KNSA |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 62.35 |
| Support Level | N/A | $39.42 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.00 | 3.57 |
| MACD | 0.00 | 0.68 |
| Stochastic Oscillator | 0.00 | 58.25 |
Price Performance
Historical ComparisonAbout UNF Unifirst Corporation
UniFirst Corp provides uniform and workwear programs, facility management, and safety supplies and services across North America. It designs, manufactures, rents, cleans, and sells uniforms and protective clothing, including flame-resistant and high-visibility garments. It also offers industrial wiping products, floor mats, cleaning supplies, first aid cabinets, and fire protection services such as inspection and maintenance. Serving various industries, the company provides customized uniforms and specialized cleaning for nuclear and cleanroom facilities. It operates through three segments: Uniform & Facility Service Solutions, First Aid & Safety Solutions, and Other, with the majority of revenue from Uniform & Facility Service Solutions.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.